Associate Director Clinical Operations IT
Posted on: 29 Jan 2022
Cambridge, MA
Job Description
Job Description
Oversee the Global Clinical Operations IT organization and business relationships. Serve as the IT strategic partner and primary liaison for the GCO Business Process Management organization. Manage all GCO IT related projects across various business units. Leads R&D IT Development portfolio management and teams within the Development. Work closely with the GSRS IT, Regulatory IT and ADS IT organizations. Accountable for keeping Biogen's GCO IT regulatory and compliance standards in the regions/countries. Provide IT service management needs for the GCO Platform Champion of communication between the GCO, ADS, TCoe, ITQ, Research IT and IT.
Key Responsibilities:
Translating: Understand GCO business function and strategy and effectively translate IT strategies into opportunities and requirements for technology solutions.
Anticipating/Influencing: Proactively anticipate business needs to shape demand for GCO IT services.
Strategic Planning: Develop functional roadmaps that are aligned with function’s strategy and priorities for the GCO organization.
Developing/Managing Relationships: Engage and develop relationships with the right functional partners (e.g., GCO and other Steering Committees (e.g. DANTE) and subject matter experts. Manage and build trust in these relationships.
Integrating: Integrate roadmaps developed by other enabling GCO functions with business partners to align IT capabilities with functional demand for IT services.
Advocating: Advocate for partners with GCO colleagues as needed/appropriate. In turn, drive awareness and adoption of GCO IT initiatives and changes driven by all regulatory and compliance standards in the region/countries.
Create a positive work environment by understanding people’s strengths and growth areas – both in the hiring and ongoing work assignment process – and by matching the right talent to the right professional needs and opportunities.
Qualifications
Minimum Experience Requirements:
Understanding of the Biopharma industry landscape of vendors and technology
Minimum of 7-10 years working in the biopharmaceutical R&D in a leadership role
Experience overseeing IT Development services and systems globally
Experience developing and leading high performing teams and budgets
Demonstrated ability to work and influence at multiple levels within mixed organization
Direct experience working with outsourced/managed service providers
Solid analytical, problem-solving, and troubleshooting abilities.
Strong written and verbal communication skills with the demonstrated ability to work and influence at multiple levels.
Minimum Knowledge Requirements:
Bachelor’s Degree in Computer Science, advanced degree in business or information technology desirable or a combination of degree and related experience that exceeds the minimum qualifications.
Biogen
Cambridge, MA
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; and IMRALDI, an adalimumab biosimilar referencing HUMIRA. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies.
Further, it is involved in developing BIIB098, Opicinumab, and BIIB061 for MS and neuroimmunology; Aducanumab, Elenbecestat, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB092 and BIIB054 for treating Parkinson's disease and movement disorders; BIIB067, BIIB078, and BIIB110 to treat neuromuscular disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB104 for treating neurocognitive disorders; BIIB074 and BIIB095 for pain; and Dapirolzumab pegol, BG00011, and BIIB059 for treating other diseases, which are under various stages of development.
The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc., Eisai Co., Ltd., Alkermes Pharma Ireland Limited, Bristol-Myers Squibb Company, Acorda Therapeutics, Inc., AbbVie Inc., C4 Therapeutics, University of Pennsylvania, Applied Genetic Technologies Corporation, and others. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
-
IndustryBiotechnology
-
No. of Employees7,800
-
Website
-
Jobs Posted445
